KR100649855B1 - β-글루칸 함유 조성물 및 상기 조성물을 이용한 변비개선제, 면역 부활제 및 피부용 보습제 - Google Patents
β-글루칸 함유 조성물 및 상기 조성물을 이용한 변비개선제, 면역 부활제 및 피부용 보습제 Download PDFInfo
- Publication number
- KR100649855B1 KR100649855B1 KR1020057004241A KR20057004241A KR100649855B1 KR 100649855 B1 KR100649855 B1 KR 100649855B1 KR 1020057004241 A KR1020057004241 A KR 1020057004241A KR 20057004241 A KR20057004241 A KR 20057004241A KR 100649855 B1 KR100649855 B1 KR 100649855B1
- Authority
- KR
- South Korea
- Prior art keywords
- glucan
- lactic acid
- acid bacteria
- aureobasidium
- culture
- Prior art date
Links
- 229920001503 Glucan Polymers 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 206010010774 Constipation Diseases 0.000 title claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 title description 7
- 229940079593 drug Drugs 0.000 title description 2
- 230000000091 immunopotentiator Effects 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 128
- 241000894006 Bacteria Species 0.000 claims abstract description 106
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 64
- 239000004310 lactic acid Substances 0.000 claims abstract description 64
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 39
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 33
- 241000879125 Aureobasidium sp. Species 0.000 claims abstract description 20
- 239000004480 active ingredient Substances 0.000 claims abstract description 16
- 239000007787 solid Substances 0.000 claims abstract description 14
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 11
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 11
- 239000004909 Moisturizer Substances 0.000 claims abstract description 10
- 238000012258 culturing Methods 0.000 claims abstract description 10
- 230000001333 moisturizer Effects 0.000 claims abstract description 10
- 241000223678 Aureobasidium pullulans Species 0.000 claims abstract description 8
- 239000003022 immunostimulating agent Substances 0.000 claims description 2
- 241000223651 Aureobasidium Species 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003020 moisturizing effect Effects 0.000 abstract description 13
- 239000012190 activator Substances 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 230000001766 physiological effect Effects 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 description 52
- 238000012360 testing method Methods 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 21
- 230000004083 survival effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 238000011081 inoculation Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 230000001954 sterilising effect Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 241000186781 Listeria Species 0.000 description 7
- 210000001744 T-lymphocyte Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920000869 Homopolysaccharide Polymers 0.000 description 3
- 102100037850 Interferon gamma Human genes 0.000 description 3
- 108010074328 Interferon-gamma Proteins 0.000 description 3
- 244000199866 Lactobacillus casei Species 0.000 description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 229940017800 lactobacillus casei Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 241001480003 Chaetothyriales Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 102100025137 Early activation antigen CD69 Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000194031 Enterococcus faecium Species 0.000 description 2
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 2
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 2
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000013611 frozen food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- -1 hair dressings Substances 0.000 description 2
- 230000008076 immune mechanism Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101000957724 Catostomus commersonii Corticoliberin-1 Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003699 hair surface Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000002861 immature t-cell Anatomy 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
Abstract
Description
Claims (8)
- 아우레오바시디움속(Aureobasidium sp.)에 속하는 균을 배양하여 얻어지는 β-1,3-1,6-글루칸을 포함하는 배양물과, 가열살균된 유산구균 엔테로코커스 패칼리스(Enterococcus faecalis)를 유효성분으로서 함유하는 것을 특징으로 하는 β-글루칸 함유 조성물.
- 제1항에 있어서, 상기 아우레오바시디움속(Aureobasidium sp.)에 속하는 균은, 아우레오바시디움 플루란스 M-1(Aureobasidium pullulans M-1)(FERM BP-08615)인 β-글루칸 함유 조성물.
- 제1항 또는 제2항에 있어서, 고형분 중에 상기 배양물을 β-1,3-1,6-글루칸 환산으로 1~80 질량% 함유하고, 또한 상기 유산균 균체를 4~95 질량% 함유하는 β-글루칸 함유 조성물.
- 삭제
- 삭제
- 제1항의 β-글루칸 함유 조성물을 유효성분으로서 함유하는 변비 개선제.
- 제1항의 β-글루칸 함유 조성물을 유효성분으로서 함유하는 면역 부활제.
- 제1항의 β-글루칸 함유 조성물을 유효성분으로서 함유하는 피부용 보습제.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003061379A JP4054697B2 (ja) | 2003-03-07 | 2003-03-07 | 便秘改善剤 |
JPJP-P-2003-00061382 | 2003-03-07 | ||
JPJP-P-2003-00061379 | 2003-03-07 | ||
JP2003061382A JP4000078B2 (ja) | 2003-03-07 | 2003-03-07 | 皮膚用保湿剤 |
JPJP-P-2004-00028965 | 2004-02-05 | ||
JP2004028965A JP4369258B2 (ja) | 2004-02-05 | 2004-02-05 | 免疫賦活剤 |
PCT/JP2004/002780 WO2004078188A1 (ja) | 2003-03-07 | 2004-03-04 | βーグルカン含有組成物及び該組成物を利用した便秘改善剤、免疫賦活剤並びに皮膚用保湿剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050115854A KR20050115854A (ko) | 2005-12-08 |
KR100649855B1 true KR100649855B1 (ko) | 2006-11-28 |
Family
ID=32966293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057004241A KR100649855B1 (ko) | 2003-03-07 | 2004-03-04 | β-글루칸 함유 조성물 및 상기 조성물을 이용한 변비개선제, 면역 부활제 및 피부용 보습제 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050272694A1 (ko) |
EP (1) | EP1602377B1 (ko) |
KR (1) | KR100649855B1 (ko) |
CN (1) | CN100341521C (ko) |
AT (1) | ATE519490T1 (ko) |
HK (1) | HK1083590A1 (ko) |
TW (1) | TWI282279B (ko) |
WO (1) | WO2004078188A1 (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100341521C (zh) * | 2003-03-07 | 2007-10-10 | 奥力有限公司 | 含β-葡聚糖的组合物 |
JP4268105B2 (ja) * | 2004-09-09 | 2009-05-27 | 株式会社アウレオ | β−グルカン含有組成物、その製造方法及び該組成物を含む飲食品若しくは皮膚用保湿剤 |
KR100666055B1 (ko) | 2005-01-19 | 2007-01-09 | 한국효소 주식회사 | 수용성 베타글루칸의 제조방법 |
JP4777365B2 (ja) * | 2005-02-15 | 2011-09-21 | シャーウッド エル. ゴルバック | プロバイオティクスおよび単離されたβ−グルカンを含有する食物ならびにその使用方法 |
KR100709289B1 (ko) * | 2005-09-23 | 2007-04-19 | 주식회사 글루칸 | β-글루칸을 포함하는 항암 및 면역 기능 증강용 약학조성물 |
KR101106077B1 (ko) * | 2006-08-10 | 2012-01-18 | 하우스 웰니스 푸드 코퍼레이션 | 보습제 |
EP2630961B1 (en) * | 2006-11-02 | 2014-11-26 | Aureo Co., Ltd. | Agent for promoting healing of a wound of a living body |
WO2009063221A2 (en) * | 2007-11-13 | 2009-05-22 | Biotec Pharmacon Asa | Methods of treating or preventing inflammatory diseases of the intestinal tract |
KR100993577B1 (ko) * | 2008-06-19 | 2010-11-10 | 한국생명공학연구원 | 신균주 아우레오바시디움 풀루란스 np-1221 kctc11265bp 및 이를 이용하여 세포외 분비형 베타-글루칸을생산하는 방법 |
US20100233128A1 (en) * | 2009-03-13 | 2010-09-16 | Mci Media Capital Inc. | Natural Skin Products Containing Dairy and Processes |
CN101953855A (zh) * | 2009-07-21 | 2011-01-26 | 明博医药技术开发(上海)有限公司 | 一种乳酸菌细胞壁裂解物的制备方法和用途 |
TWI496578B (zh) * | 2009-10-08 | 2015-08-21 | Aureo Co Ltd | 流感病毒感染症的治療劑 |
CN102732468B (zh) * | 2012-07-06 | 2014-04-23 | 北京农学院 | 一株粪肠球菌及其广谱抑菌作用 |
KR102189084B1 (ko) * | 2013-08-30 | 2020-12-10 | 주식회사 아리바이오 | 흑효모 배양액을 포함하는 피부상태 개선용 화장료 조성물 |
JP6146676B2 (ja) * | 2013-10-09 | 2017-06-14 | 東レ株式会社 | 免疫賦活化剤 |
US8937791B1 (en) | 2013-11-27 | 2015-01-20 | Seagate Technology Llc | Slider having heater with adjacent high thermal conductivity layer |
KR101693574B1 (ko) * | 2014-09-23 | 2017-01-06 | 한국 한의학 연구원 | 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물 |
JP6185041B2 (ja) * | 2015-12-04 | 2017-08-23 | 一丸ファルコス株式会社 | 表皮ブドウ球菌由来のグリセロール産生促進剤、皮膚表皮角化細胞由来の抗菌ペプチド産生促進剤、およびそれらの皮膚保護用外用剤への利用 |
JP2019510037A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | 抗菌ペプチド刺激性洗浄組成物 |
WO2017173241A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
CN106509918A (zh) * | 2016-11-15 | 2017-03-22 | 金建文 | 一种以食品级β‑葡聚糖为主要原料,促进排毒通便、提高免疫力的组合物及其制备方法 |
CA3043748A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
TWI623616B (zh) * | 2016-11-30 | 2018-05-11 | 財團法人食品工業發展研究所 | 黑酵母菌、生產β-葡聚糖之培養基與方法、黑酵母菌培養物與含其組成物 |
US10260080B2 (en) | 2016-11-30 | 2019-04-16 | Food Industry Research And Development Institute | Aureobasidium pullulans, culturing medium and method for producing B-glucan, a culture of aureobasidium pullulans and a composition comprising the same |
CN111491644A (zh) | 2017-11-20 | 2020-08-04 | 株式会社爱茉莉太平洋 | 包含出芽短梗霉菌株的培养物或者提取物的用于改善微细粉尘引起的皮肤损伤的组合物 |
KR102096545B1 (ko) * | 2019-08-27 | 2020-04-03 | 주식회사 아리바이오 | 멜라닌색소를 생산하지 않는 베타-글루칸 고생산성 오레오바시디움 풀루란스 균주를 이용한 피부 보습, 주름개선 및 미백용 화장료 조성물 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61146192A (ja) * | 1984-12-17 | 1986-07-03 | Satoshi Shinohara | フラクトオリゴ糖とβ―1.3―1.6グルカンを主成分とする飲食物の製造方法 |
JPS62205008A (ja) * | 1986-03-05 | 1987-09-09 | Bio Bai Daimaru:Kk | 化粧品等の添加剤 |
JPH01137990A (ja) * | 1987-11-20 | 1989-05-30 | Daiichi Togyo Kk | ビフィズス菌の増殖活性を有する多糖 |
AUPO430496A0 (en) * | 1996-12-19 | 1997-01-23 | Arnott's Biscuits Limited | Prebiotics and probiotics |
JPH10310515A (ja) * | 1997-05-10 | 1998-11-24 | Tomoko Saegusa | 入浴剤 |
NL1010770C2 (nl) * | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
JP2001048796A (ja) * | 1999-08-10 | 2001-02-20 | Advance Co Ltd | 感染症予防機能及び免疫関連疾患の軽減機能を有する腸内細菌由来乳酸菌エキス及び死菌体粉末とその食品応用 |
JP2001190231A (ja) * | 1999-10-29 | 2001-07-17 | Oriental Yeast Co Ltd | 養魚用の抗病性組成物およびその使用方法 |
JP2001231589A (ja) * | 2000-02-18 | 2001-08-28 | Sofi:Kk | 乳酸の発酵方法 |
JP4812157B2 (ja) * | 2000-05-16 | 2011-11-09 | 株式会社Adeka | 免疫増強作用を有する低分子化βグルカンを含有する医薬品素材 |
JP2001354570A (ja) * | 2000-06-15 | 2001-12-25 | Ichimaru Pharcos Co Ltd | 免疫賦活剤及びそれを利用した香粧品 |
JP4336930B2 (ja) * | 2000-12-15 | 2009-09-30 | サンスター株式会社 | 乳酸菌発酵液の製造方法及び該発酵液を原料とする食品 |
JP2002239494A (ja) * | 2001-02-15 | 2002-08-27 | Kawasaki Heavy Ind Ltd | 屎尿等処理方法及びその装置 |
JP3523220B2 (ja) * | 2001-05-14 | 2004-04-26 | 一光化学株式会社 | 皮膚塗布剤 |
JP4499979B2 (ja) * | 2001-05-21 | 2010-07-14 | コンビ株式会社 | 病原菌感染抑制用組成物 |
DE20202562U1 (de) * | 2002-02-19 | 2002-05-23 | Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld | Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika |
JP2004121192A (ja) * | 2002-10-01 | 2004-04-22 | Katsunori Kodama | アウレオバシジウム培養液を添加することによる乳酸菌強化乳発酵食品の製造方法及び乳酸菌強化乳発酵食品 |
CN100341521C (zh) * | 2003-03-07 | 2007-10-10 | 奥力有限公司 | 含β-葡聚糖的组合物 |
-
2004
- 2004-03-04 CN CNB2004800010385A patent/CN100341521C/zh not_active Expired - Lifetime
- 2004-03-04 KR KR1020057004241A patent/KR100649855B1/ko active IP Right Grant
- 2004-03-04 US US10/531,463 patent/US20050272694A1/en not_active Abandoned
- 2004-03-04 WO PCT/JP2004/002780 patent/WO2004078188A1/ja active Application Filing
- 2004-03-04 EP EP04717235A patent/EP1602377B1/en not_active Expired - Lifetime
- 2004-03-04 AT AT04717235T patent/ATE519490T1/de not_active IP Right Cessation
- 2004-03-05 TW TWCOMPOSITIA patent/TWI282279B/zh not_active IP Right Cessation
-
2006
- 2006-03-24 HK HK06103700A patent/HK1083590A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1083590A1 (en) | 2006-07-07 |
EP1602377A4 (en) | 2009-06-24 |
KR20050115854A (ko) | 2005-12-08 |
EP1602377B1 (en) | 2011-08-10 |
US20050272694A1 (en) | 2005-12-08 |
TWI282279B (en) | 2007-06-11 |
ATE519490T1 (de) | 2011-08-15 |
CN1700926A (zh) | 2005-11-23 |
EP1602377A1 (en) | 2005-12-07 |
TW200509947A (en) | 2005-03-16 |
WO2004078188A1 (ja) | 2004-09-16 |
CN100341521C (zh) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100649855B1 (ko) | β-글루칸 함유 조성물 및 상기 조성물을 이용한 변비개선제, 면역 부활제 및 피부용 보습제 | |
Bajpai et al. | Exopolysaccharide and lactic acid bacteria: Perception, functionality and prospects | |
JP5737646B2 (ja) | 抗アレルギー剤 | |
JP5982376B2 (ja) | 口腔内疾患の予防又は治療剤 | |
AU2018251694B2 (en) | Multifiber prebiotic composition for digestive health, weight control, boosting immunity and improving health | |
US6956120B2 (en) | β-1.3-1.6 glucan (Aureobasidium medium) | |
WO2006027914A1 (ja) | β-グルカン含有組成物、その製造方法及び該組成物を含む飲食品若しくは皮膚用保湿剤 | |
US9737575B2 (en) | Use of lactic acid bacteria to treat or prevent eczema | |
KR20050057259A (ko) | 프로바이오틱 박테리아 : 락토바실러스 퍼멘텀 | |
TWI689585B (zh) | 新穎乳酸菌株及包含新穎乳酸菌株之免疫賦活劑 | |
EP1615657A1 (fr) | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant | |
JP4369258B2 (ja) | 免疫賦活剤 | |
Mi et al. | Immune-enhancing effects of postbiotic produced by Bacillus velezensis Kh2-2 isolated from Korea Foods | |
JP4807941B2 (ja) | βグルカン | |
JP2004269408A (ja) | 皮膚用保湿剤 | |
JP4054697B2 (ja) | 便秘改善剤 | |
JP6842014B2 (ja) | トロンボスポンジン1遺伝子発現亢進用組成物 | |
Takada et al. | Inhibition of plaque and caries formation by a glucan produced by Streptococcus mutans mutant UAB108 | |
CN114340669A (zh) | 用于增强抗体药物的效果的组合物 | |
JP2009143854A (ja) | 創傷治癒促進剤 | |
TWI827293B (zh) | 羅伊氏乳桿菌tci850及其提高免疫力及抗發炎用途 | |
KR20100138439A (ko) | 푸코 올리고당을 포함하는 면역세포 활성화용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120807 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130813 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140812 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150820 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160816 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170822 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180808 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20191002 Year of fee payment: 14 |